You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Growth boosts Thermo Fisher

Thermo Fisher’s drug ID scanner.

Steven Senne/AP/File

Thermo Fisher’s drug ID scanner.

Thermo Fisher Scientific Inc.’s third-quarter earnings climbed 9 percent, helped by revenue growth in key segments, and the Waltham scientific instrument and laboratory supply maker raised its forecast for 2012. The company said it earned $290.4 million, or 79 cents per share, compared to $265.4 million, or 69 cents, in last year’s quarter. Revenue grew 5 percent to $3.09 billion. The performance beat Wall Street expectations. Thermo Fisher expects adjusted 2012 earnings of $4.81 to $4.88 per share, up from its forecast $4.74 to $4.84.

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.